Wang Qiwen

Mr. Wang Qiwen is a senior investment professional with over 20 years of private equity investment experience. Mr. Wang is now CEO and partner of CoStone Capital, and responsible for PE investment and corporate finance, he is based in Shenzhen. Mr. Wang was also involved in numerous CoStone Capital investments including Dezhan Health (and its subsidiary Jialin Pharmaceutical), Hutian New Material(300041), ZCCCT, CKIC(300338), Kexin(300565), CSII(300663), Snibe,Mindary(872404), Medprin(300760), ZIMT, Bright Eye Hospital and Pagoda.

Mr. Wang has worked as investment director of Eagle Venture Capital from 2002 to 2008, and as a deputy general manager of Eagle Securities investment bank department from 1997 to 2002. Before joining Eagle Securities, Mr. Wang worked as general manager in capital planning department in Hainan Airport from 1994 to 1997. Prior to this role, Mr. Wang was a deputy general manager responsible for financing and accounting in Dongfeng Motor from 1988 to 1994. Mr. Wang received his B.A. in economics from Central University of Finance and Economics, and his EMBA from GuangHua School of Management, Peking University.